15 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 Nov 21
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results
6:56am
medicines. Backed by an expert team and a strong balance sheet, we stand well positioned to advance our gene editing therapies and fundamentally change
S-1
EX-10.11
8dt0jrnt75qdrxq gx
28 May 21
IPO registration
4:04pm
S-1
EX-10.17
5kc561dq w1zhq6x
28 May 21
IPO registration
4:04pm
S-1
EX-10.12
z69qtfou ps7w
28 May 21
IPO registration
4:04pm
S-1
EX-10.9
y5y641 ma7r
28 May 21
IPO registration
4:04pm
S-1
EX-10.13
2p9y351f q7zb8jd7
28 May 21
IPO registration
4:04pm
DRS
EX-10.13
m1qeem uw9
16 Apr 21
Draft registration statement
12:00am
DRS
chat108c
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.10
lmnhl
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.12
acgxqsl
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.14
1dpfv5jk wm6bz
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next